“Customer’s loyalty is more priceless,than customer’s satisfaction.“
Founder – Late Shri. Rameshchandra Khokhani
Introduction
Shamrock Pharmachemi is a part of Shamrock Group, which is involved in Contract Manufacturing, and export of APIs, Intermediates and Veterinary products for over 23 years. Over this period Shamrock has established itself as a recognizable brand promoting Indian APIs and Intermediates internationally.
Historical milestone achieved indicates the company’s strength in penetrating markets and customers easily than the biggest Pharma giants can ever fathom in spite of having young guns in their team. Shamrock believes “Together We Can Improve the Quality of Life” world over making a difference & enhancing customer satisfaction in the process improving health care solutions thereby transforming the lives of millions.
Our business model includes Exclusive Manufacturing, Contract Manufacturing and Outsourcing. We maintain the highest quality standards backed by complete Regulatory Approval and Documentation – cGMP, EUGMP, WHOGMP, FDA with DMF, CTD Dossiers, CEP etc. and these are provided to our customers along with quality audits by independent approved auditors.
Years of experience
in pharmaceutical
industry
Active
Registration with
XYZ
DMFS filed in
Regulatory
markets
Country
exporting
currently
Vision
To bridge the gap between premium quality products & customer service for the pharmaceutical industry, for both human society and animal healthcare. We promote & market effective, safe and high-quality products, adding value of additional service to better serve our customers by competing in the global environment and subsequently improving the quality of life.
Mission
To become a major global player in service of the Pharmaceutical & Health Care Industry, strategically placing ourselves as a market and customer driven company.
Milestone
- Pioneered International Export Marketing & Sales from India on a long-term Contract Manufacturing basis with Overseas Generic FDA Approved producers.
- Pioneers in entering the South American Market, Brazil, Argentina, Georgia, Paraguay, Colombia & Mexico.
- Entered Iraq Market & obtained Tender Business with $80 Million. 1st company from India to Transfer Technology from India to API Stage with Buy Back Agreement.
- Similarly, 1st Company from India to Transfer Finished Products Technology against Buy Back of API’s with the Regulatory Documentation.
- 1st Company from India to enter Iran Market for Intermediates with Technology Transfer and Buy Back Agreements.
Management Team
Leadership is the capacity to translate vision to reality and we believe “Together we can improve the quality of life”
Business Model
FACTORY APPROVALS:
cGMP, WHO GMP, USFDA, EUGMP, COS, DMF, TIP, KFDA, ANVISA, COFEPRIS, UK MHRA, TGA
News & Events
